{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T15:37:08Z","timestamp":1776958628701,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,23]]},"DOI":"10.7759\/cureus.107590","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:43:01Z","timestamp":1776955381000},"source":"Crossref","is-referenced-by-count":0,"title":["Difference in Background Parenchymal Enhancement on Contrast-Enhanced Mammography in Treatment-Na\u00efve Versus Systemic Neoadjuvant Chemotherapy Patients"],"prefix":"10.7759","author":[{"given":"Oi Hang","family":"Hoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"San Yu","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsz Yan","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwun Man","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yee Tak","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-63. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/jbi\/wbaa110","article-title":"Molecular subtypes of breast cancer: a review for breast radiologists","volume":"3","author":"Johnson KS","year":"2021","unstructured":"Johnson KS, Conant EF, Soo MS. Molecular subtypes of breast cancer: a review for breast radiologists. J Breast Imaging. 2021, 3:12-24. 10.1093\/jbi\/wbaa110","journal-title":"J Breast Imaging"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021201948","article-title":"Contrast-enhanced mammography: state of the art","volume":"299","author":"Jochelson MS","year":"2021","unstructured":"Jochelson MS, Lobbes MB. Contrast-enhanced mammography: state of the art. Radiology. 2021, 299:36-48. 10.1148\/radiol.2021201948","journal-title":"Radiology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.230530","article-title":"Comparison of contrast-enhanced mammography with MRI utilizing an enriched reader study: a breast cancer study (CONTRRAST Trial)","volume":"309","author":"Phillips J","year":"2023","unstructured":"Phillips J, Mehta TS, Portnow LH, Fishman MD, Zhang Z, Pisano ED. Comparison of contrast-enhanced mammography with MRI utilizing an enriched reader study: a breast cancer study (CONTRRAST Trial). Radiology. 2023, 309:e230530. 10.1148\/radiol.230530","journal-title":"Radiology"},{"key":"ref5","article-title":"BI-RADS\u00ae. ACR Breast Imaging Reporting and Data System","author":"Newell MS","year":"2025","unstructured":"Newell MS, Destounis SV, Leung JWT, et al.. BI-RADS\u00ae. ACR Breast Imaging Reporting and Data System. American College of Radiology, Reston, VA; 2025."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.18.20566","article-title":"Effect of background parenchymal enhancement on cancer risk across different high-risk patient populations undergoing screening breast MRI","volume":"212","author":"Sippo DA","year":"2019","unstructured":"Sippo DA, Rutledge GM, Burk KS, Mercaldo SF, Dontchos BN, Edmonds CE, Lehman CD. Effect of background parenchymal enhancement on cancer risk across different high-risk patient populations undergoing screening breast MRI. AJR Am J Roentgenol. 2019, 212:1412-8. 10.2214\/AJR.18.20566","journal-title":"AJR Am J Roentgenol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.230367","article-title":"Association of breast cancer odds with background parenchymal enhancement quantified using a fully automated method at MRI: the IMAGINE study","volume":"308","author":"Watt GP","year":"2023","unstructured":"Watt GP, Thakran S, Sung JS, et al.. Association of breast cancer odds with background parenchymal enhancement quantified using a fully automated method at MRI: the IMAGINE study. Radiology. 2023, 308:e230367. 10.1148\/radiol.230367","journal-title":"Radiology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics16030495","article-title":"Review of prognostic significance of quantitative BPE measurements","volume":"16","author":"Weiss J","year":"2026","unstructured":"Weiss J, Hunt E, Zhu Y, Duong TQ, Maldjian T. Review of prognostic significance of quantitative BPE measurements. Diagnostics (Basel). 2026, 16:5. 10.3390\/diagnostics16030495","journal-title":"Diagnostics (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.12773","article-title":"Background parenchymal enhancement in contrast-enhanced spectral mammography: a retrospective analysis and a pictorial review of clinical cases","volume":"36","author":"Meucci R","year":"2022","unstructured":"Meucci R, Pistolese CA, Perretta T, et al.. Background parenchymal enhancement in contrast-enhanced spectral mammography: a retrospective analysis and a pictorial review of clinical cases. In Vivo. 2022, 36:853-8. 10.21873\/invivo.12773","journal-title":"In Vivo"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021203645","article-title":"Breast MRI during neoadjuvant chemotherapy: lack of background parenchymal enhancement suppression and inferior treatment response","volume":"301","author":"Onishi N","year":"2021","unstructured":"Onishi N, Li W, Newitt DC, et al.. Breast MRI during neoadjuvant chemotherapy: lack of background parenchymal enhancement suppression and inferior treatment response. Radiology. 2021, 301:295-308. 10.1148\/radiol.2021203645","journal-title":"Radiology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55820-5","article-title":"Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer","volume":"9","author":"Moliere S","year":"2019","unstructured":"Moliere S, Oddou I, Noblet V, Veillon F, Mathelin C. Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer. Sci Rep. 2019, 9:19185. 10.1038\/s41598-019-55820-5","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20170550","article-title":"Relationship between background parenchymal enhancement on breast MRI and pathological tumor response in breast cancer patients receiving neoadjuvant chemotherapy","volume":"91","author":"Oh SJ","year":"2018","unstructured":"Oh SJ, Chae EY, Cha JH, Shin HJ, Choi WJ, Kim HH. Relationship between background parenchymal enhancement on breast MRI and pathological tumor response in breast cancer patients receiving neoadjuvant chemotherapy. Br J Radiol. 2018, 91:5. 10.1259\/bjr.20170550","journal-title":"Br J Radiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11040256","article-title":"Response predictivity to neoadjuvant therapies in breast cancer: a qualitative analysis of background parenchymal enhancement in DCE-MRI","volume":"11","author":"La Forgia D","year":"2021","unstructured":"La Forgia D, Vestito A, Lasciarrea M, et al.. Response predictivity to neoadjuvant therapies in breast cancer: a qualitative analysis of background parenchymal enhancement in DCE-MRI. J Pers Med. 2021, 11:6. 10.3390\/jpm11040256","journal-title":"J Pers Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1590\/0100-3984.2019.0057","article-title":"Background parenchymal enhancement: behavior during neoadjuvant chemotherapy for breast cancer and relationship with a pathological complete response","volume":"53","author":"Teixeira SR","year":"2020","unstructured":"Teixeira SR, de Camargo J\u00fanior HS, Cabello C. Background parenchymal enhancement: behavior during neoadjuvant chemotherapy for breast cancer and relationship with a pathological complete response. Radiol Bras. 2020, 53:95-104. 10.1590\/0100-3984.2019.0057","journal-title":"Radiol Bras"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2013.07.014","article-title":"Background parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI","volume":"31","author":"Chen JH","year":"2013","unstructured":"Chen JH, Yu H, Lin M, Mehta RS, Su MY. Background parenchymal enhancement in the contralateral normal breast of patients undergoing neoadjuvant chemotherapy measured by DCE-MRI. Magn Reson Imaging. 2013, 31:1465-71. 10.1016\/j.mri.2013.07.014","journal-title":"Magn Reson Imaging"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15222826","article-title":"Comparison of contralateral breast background parenchymal enhancement on MRI before and after neoadjuvant chemotherapy according to molecular subtypes in unilateral breast cancer","volume":"15","author":"Kim MY","year":"2025","unstructured":"Kim MY, Choi N, Park S, Seo J, Ahn SY, Shin YJ. Comparison of contralateral breast background parenchymal enhancement on MRI before and after neoadjuvant chemotherapy according to molecular subtypes in unilateral breast cancer. Diagnostics (Basel). 2025, 15:5. 10.3390\/diagnostics15222826","journal-title":"Diagnostics (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-015-4011-x","article-title":"Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response","volume":"26","author":"Preibsch H","year":"2016","unstructured":"Preibsch H, Wanner L, Bahrs SD, et al.. Background parenchymal enhancement in breast MRI before and after neoadjuvant chemotherapy: correlation with tumour response. Eur Radiol. 2016, 26:1590-6. 10.1007\/s00330-015-4011-x","journal-title":"Eur Radiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109883","article-title":"Contrast enhanced mammography (CEM) versus magnetic resonance imaging (MRI) for staging of breast cancer: The pro CEM perspective","volume":"142","author":"Lobbes MB","year":"2021","unstructured":"Lobbes MB, Heuts EM, Moossdorff M, van Nijnatten TJ. Contrast enhanced mammography (CEM) versus magnetic resonance imaging (MRI) for staging of breast cancer: The pro CEM perspective. Eur J Radiol. 2021, 142:3. 10.1016\/j.ejrad.2021.109883","journal-title":"Eur J Radiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-017-0899-1","article-title":"Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging","volume":"19","author":"Iotti V","year":"2017","unstructured":"Iotti V, Ravaioli S, Vacondio R, et al.. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging. Breast Cancer Res. 2017, 19:106. 10.1186\/s13058-017-0899-1","journal-title":"Breast Cancer Res"},{"key":"ref20","article-title":"Background parenchymal enhancement in preoperative breast MRI","volume":"77","author":"Kohara S","year":"2015","unstructured":"Kohara S, Ishigaki S, Satake H, Kawamura A, Kawai H, Kikumori T, Naganawa S. Background parenchymal enhancement in preoperative breast MRI. Nagoya J Med Sci. 2015, 77:373-82.","journal-title":"Nagoya J Med Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-012-2553-8","article-title":"Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI","volume":"22","author":"King V","year":"2012","unstructured":"King V, Gu Y, Kaplan JB, Brooks JD, Pike MC, Morris EA. Impact of menopausal status on background parenchymal enhancement and fibroglandular tissue on breast MRI. Eur Radiol. 2012, 22:2641-7. 10.1007\/s00330-012-2553-8","journal-title":"Eur Radiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02864","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: ASCO-College of American Pathologists guideline update","volume":"41","author":"Wolff AC","year":"2023","unstructured":"Wolff AC, Somerfield MR, Dowsett M, et al.. Human epidermal growth factor receptor 2 testing in breast cancer: ASCO-College of American Pathologists guideline update. J Clin Oncol. 2023, 41:3867-72. 10.1200\/JCO.22.02864","journal-title":"J Clin Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2017.07.005","article-title":"Association between background parenchymal enhancement and pathologic complete remission throughout the neoadjuvant chemotherapy in breast cancer patients","volume":"10","author":"You C","year":"2017","unstructured":"You C, Peng W, Zhi W, et al.. Association between background parenchymal enhancement and pathologic complete remission throughout the neoadjuvant chemotherapy in breast cancer patients. Transl Oncol. 2017, 10:786-92. 10.1016\/j.tranon.2017.07.005","journal-title":"Transl Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2021210967","article-title":"MRI background parenchymal enhancement and neoadjuvant chemotherapy response","volume":"301","author":"Philpotts LE","year":"2021","unstructured":"Philpotts LE. MRI background parenchymal enhancement and neoadjuvant chemotherapy response. Radiology. 2021, 301:309-10. 10.1148\/radiol.2021210967","journal-title":"Radiology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.12809\/hkjr2417807","article-title":"Uses of contrast-enhanced mammography in a regional clinical institute: a pictorial essay","volume":"28","author":"Hui CN","year":"2025","unstructured":"Hui CN, Ko BTY, Mo CKM, Lai AYT, Wong WWC. Uses of contrast-enhanced mammography in a regional clinical institute: a pictorial essay. Hong Kong J Radiol. 2025, 28:e204-16. 10.12809\/hkjr2417807","journal-title":"Hong Kong J Radiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/482911-difference-in-background-parenchymal-enhancement-on-contrast-enhanced-mammography-in-treatment-nave-versus-systemic-neoadjuvant-chemotherapy-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:43:02Z","timestamp":1776955382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/482911-difference-in-background-parenchymal-enhancement-on-contrast-enhanced-mammography-in-treatment-nave-versus-systemic-neoadjuvant-chemotherapy-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.107590","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,23]]}}}